On the other hand, insulin-secreting cell lines like RIN, HIT, MIN, INS-1, βTC cells (10) and also the glucagon-like peptide-1 (GLP-1) promoter, which is in gut L-cells and is a good candidate for diabetes mellitus gene therapy, are recently used. The gene discussed is GCG; the disease is diabetes mellitus.